Hemophilia A (HA) is a congenital bleeding disorder characterized by a deficiency of factor VIII (FVIII), leading to impaired hemostasis and a high risk of bleeding—particularly joint bleeds—resulting in a functional deterioration and a reduced quality of life. This evidence concerns the gene F8 and hemophilia A.